322 related articles for article (PubMed ID: 9084793)
1. Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion Study.
Dorrucci M; Pezzotti P; Phillips AN; Alliegro MB; Rezza G
AIDS; 1997 Mar; 11(4):461-7. PubMed ID: 9084793
[TBL] [Abstract][Full Text] [Related]
2. Determinants of progression to AIDS in HIV-infected individuals: an update from the Italian Seroconversion Study.
Rezza G
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 17 Suppl 1():S13-6. PubMed ID: 9586645
[TBL] [Abstract][Full Text] [Related]
3. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
4. Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study.
Prins M; Veugelers PJ
AIDS; 1997 Apr; 11(5):621-31. PubMed ID: 9108944
[TBL] [Abstract][Full Text] [Related]
5. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study.
Cozzi Lepri A; Pezzotti P; Dorrucci M; Phillips AN; Rezza G
BMJ; 1994 Dec; 309(6968):1537-42. PubMed ID: 7819892
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.
Detels R; Muñoz A; McFarlane G; Kingsley LA; Margolick JB; Giorgi J; Schrager LK; Phair JP
JAMA; 1998 Nov; 280(17):1497-503. PubMed ID: 9809730
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study.
Dorrucci M; Rezza G; Vlahov D; Pezzotti P; Sinicco A; Nicolosi A; Lazzarin A; Galai N; Gafà S; Pristerà R
AIDS; 1995 Jun; 9(6):597-604. PubMed ID: 7662199
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
[TBL] [Abstract][Full Text] [Related]
9. The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study.
Stein DS; Graham NM; Park LP; Hoover DR; Phair JP; Detels R; Ho M; Saah AJ
Ann Intern Med; 1994 Jul; 121(2):100-8. PubMed ID: 8017721
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category.
Pérez-Hoyos S; del Amo J; Muga R; del Romero J; García de Olalla P; Guerrero R; Hernàndez-Aguado I;
AIDS; 2003 Feb; 17(3):353-9. PubMed ID: 12556689
[TBL] [Abstract][Full Text] [Related]
11. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.
García de la Hera M; Ferreros I; del Amo J; García de Olalla P; Pérez Hoyos S; Muga R; del Romero J; Guerrero R; Hernández-Aguado I;
J Epidemiol Community Health; 2004 Nov; 58(11):944-50. PubMed ID: 15483312
[TBL] [Abstract][Full Text] [Related]
12. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe.
Lancet; 2000 Apr; 355(9210):1131-7. PubMed ID: 10791375
[TBL] [Abstract][Full Text] [Related]
13. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
[TBL] [Abstract][Full Text] [Related]
14. The impact of antiviral therapy with zidovudine: a retrospective study on HIV-positive hemophiliacs in Italy. Italian Group of Congenital Coagulopathies.
Arcieri R; Puopolo M; Baudo F; Chiarotti F; De Rosa V; Schinaia N; Mori PG; Ghirardini A
Haematologica; 1995; 80(1):25-30. PubMed ID: 7758987
[TBL] [Abstract][Full Text] [Related]
15. Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study.
Rezza G; Galai N; Pezzotti P; Vlahov D; Graham NM; Viale P; Angarano G
Antivir Ther; 1997 Jul; 2(3):167-74. PubMed ID: 11322271
[TBL] [Abstract][Full Text] [Related]
16. Pre-AIDS mortality and its association with HIV disease progression in haemophilic men, injecting drug users and homosexual men.
Prins M; Sabin CA; Lee CA; Devereux H; Coutinho RA
AIDS; 2000 Aug; 14(12):1829-37. PubMed ID: 10985321
[TBL] [Abstract][Full Text] [Related]
17. [Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].
Pezzotti P; Dorrucci M; Donisi A; Cusini M; Mazzarello G; De Luca A; Salassa B; Ursitti MA; Giuliani M; Rezza G;
Epidemiol Prev; 2003; 27(6):348-55. PubMed ID: 15058363
[TBL] [Abstract][Full Text] [Related]
18. Has the rate of progression to AIDS changed in recent years?
Carré N; Prins M; Meyer L; Brettle RP; Robertson JR; McArdle H; Goldberg DJ; Zangerle R; Coutinho RA; van den Hoek A
AIDS; 1997 Nov; 11(13):1611-8. PubMed ID: 9365766
[TBL] [Abstract][Full Text] [Related]
19. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis.
Hendriks JC; Satten GA; van Ameijden EJ; van Druten HA; Coutinho RA; van Griensven GJ
AIDS; 1998 Aug; 12(12):1537-44. PubMed ID: 9727576
[TBL] [Abstract][Full Text] [Related]
20. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study.
Graham NM; Zeger SL; Park LP; Phair JP; Detels R; Vermund SH; Ho M; Saah AJ
Lancet; 1991 Aug; 338(8762):265-9. PubMed ID: 1677108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
